Nyangau, Edna
University of California, Berkeley
2 papers on CoChatORCID 0000-0002-7430-3181
Most cited papers
- Verified
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease
Cited by 771
- Verified
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
Lawitz, E. J., Coste, A., Poordad, F., Alkhouri, N., Loo, N., McColgan, B. J., Tarrant, J. M., Nguyen, T., Han, L., Chung, C., et al. (2018) · Clinical Gastroenterology and Hepatology
Liver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection
Cited by 217
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free